Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
BioNTech SE Sponsored ADR (BNTX) had Cash Flow from Investing Activities of $300.52M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$1.78B |
|
$-33.55M |
|
$173.35M |
|
$1.60B |
|
$1.83B |
|
$-54.82M |
|
$83.69M |
|
$28.87M |
|
$28.87M |
|
$-33.55M |
|
$-33.55M |
|
$-33.55M |
|
$-33.55M |
|
$-54.82M |
|
$93.52M |
|
239.16M |
|
239.16M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$18.50B |
|
$1.22B |
|
$6.44B |
|
$24.95B |
|
$2.60B |
|
$224.43M |
|
$749.62M |
|
$3.35B |
|
$21.60B |
|
$19.56B |
|
$21.60B |
|
240.46M |
|
| Cash Flow Statement Financials | |
$171.24M |
|
|
Cash Flow from Investing Activities |
$300.52M |
$-45.12M |
|
$11.41B |
|
$11.80B |
|
$386.91M |
|
$73.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.12 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
90.24% |
|
-3.09% |
|
-3.09% |
|
-- |
|
1.63% |
|
-1.89% |
|
$45.00M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.66 |
|
1.96 |
|
45.96 |
|
-0.16% |
|
-0.17% |
|
-0.13% |
|
-0.15% |
|
$89.82 |
|
$0.19 |
|
$0.72 |
|